Cardiometabolic Response to Sit-stand Workstations.
1 other identifier
interventional
25
1 country
1
Brief Summary
We aim to determine if changing a person's workstation from a traditional seated desk to a height adjustable "standing desk" for a period of approximately 3 months is associated with alterations in traditional measures of cardiometabolic risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 14, 2015
CompletedFirst Posted
Study publicly available on registry
January 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedMay 11, 2016
May 1, 2016
1 year
January 14, 2015
May 10, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Glycoslyated Hemoglobin (HbA1C)
HbA1c will be measured at baseline and 3 months in both conditions in all participants using a bench-top analyzer.
3 months
Secondary Outcomes (9)
Sedentary Time
3 months
Aerobic Fitness (VO2max)
3 months
Augmentation Index
3 months
Waist Circumference
3 months
Physical Activity
3 months
- +4 more secondary outcomes
Study Arms (2)
Standing Desk
EXPERIMENTALWill use standing desk for 3 months
Traditional Desk
ACTIVE COMPARATORWill use traditional desk for 3 months
Interventions
Participants will use a traditional seated desk for 3 months
Eligibility Criteria
You may qualify if:
- male and female participants
- years of age and older
- work in an office-based setting.
- abdominally obese, defined as a waist circumference ≥ 88 cm for women, and 102 cm for men.
You may not qualify if:
- glucose lowering medication
- inability to stand or walk
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Human Performance and Health Research Lab, University of Prince Edward Island
Charlottetown, Prince Edward Island, C1A4P3, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamie Burr, PhD
University of Prince Edward Island
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 14, 2015
First Posted
January 19, 2015
Study Start
September 1, 2014
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
May 11, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share